Source: BIOPORTFOLIO

Spinifex: Spinifex to be acquired by Novartis

Spinifex Pharmaceuticals Inc. and its Australian subsidiary Spinifex Pharmaceuticals Pty Ltd a company focused on the development of new drugs for the treatment of chronic pain announced agreement to the sale of Spinifex to Novartis International AG for an...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Tom McCarthy's photo - President & CEO of Spinifex Pharmaceuticals Pty. Ltd.

President & CEO

Tom McCarthy

CEO Approval Rating

66/100

Read more